Role of nitric oxide modified DNA in the etiopathogenesis of systemic lupus erythematosus

Lupus

Volumn 13, Issue 2, 2004, Pages 95-100

  Dixit, K ^a   Ali, R ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Autoantibodies; Nitric oxide; NO DNA; SLE

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; NITRIC OXIDE; PLASMID DNA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISEASE ACTIVITY; DNA BINDING; DNA MODIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SERODIAGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NITRIC OXIDE; PLASMIDS;

EID: 1242314348     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu492oa     Document Type: Article

References (41)

1. Isenberg DA. Systemic lupus erythematosus: Immunopathogenesis and the cardgame analogy. J Rheumatol 1997; 42: 62-66.
2. Neparstek Y, Madaio MP. Are DNA antibodies actually pathogenic? Lupus 1997; 6: 307-309.
3. Pisetsky DS. Specificity and immunochemical properties of antibodies to bacterial DNA. Methods 1997; 11: 55-61.
4. Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiological messenger. Ann Intern Med 1994; 120: 227-237.
5. Keefer LK, Wink DA, Kasparazak KS et al. DNA deaminating ability and genotoxicty of nitric oxide and its progenitors. Science 1991; 254: 1001-1003.
6. Belmont HM, Levartovsky D, Goel A. Increased nitric oxide production accompanied by the up regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1810-1816.
7. Wanchu A, Khuller M, Deodhar SD. Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol Int 1998; 18: 41-43.
8. Oates JS, Ruiz P, Alexander A. Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopathol 1997; 83: 86-92.
9. Weinberg JB, Granger DL, Pisetsky DS. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/ lpr mice and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994; 179: 651-660.
10. Rolla G, Brussino L, Bertero MT. Increased nitric oxide in exhaled air of patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 1066-1071.
11. Gilkeson GS, Cannon C, Oates JC. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol 1999; 26: 318-324.
12. Jansson G. Formation of antibodies to native DNA in rats after administration of native DNA treated with the xanthine-xanthine oxidase system. Free Radic Res Commun 1985; 1: 119-122.
13. Hasan R, Ali R. Antibody recognition of common epitopes on Z-DNA and native DNA brominated under high salt. Biochem Int 1990; 20: 1077-1188.
14. Ali R, DerSimonian H, Stollar BD. Binding of monoclonal anti-native DNA autoantibodies to DNA of varying size and conformation. Mol Immunol 1985; 22: 1415-1422.
15. Alam K, Ali A, Ali R. The effect of hydroxyl radical on the antigenicity of native DNA. FEBS Lett 1993; 319: 66-70.
16. Ashok BT, Ali R. Antigen binding characteristics of experimentally induced antibodies against hydroxyl radical modified native DNA. Autoimmunity 1999; 29: 11-19.
17. Ahmad J, Ashok BT, Ali R. Reactive oxygen species modified thymine and poly(dT) represent unique epitopes for human anti-DNA autoantibodies. Immunol Lett 1997; 58: 69-74.
18. Ara J, Ali R. Polynucleotide specificity of anti-ROS DNA antibodies. Clin Exp Immunol 1993; 94: 134-139.
19. Dixit K, Ali R. Antigen binding characteristics of antibodies induced against nitric oxide modified plasmid DNA. Biochim Biophys Acta 2001; 1528: 1-8.
20. Andrzejewski C, Rauch J, Lafer E, Stollar BD, Schwartz RS. Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA. J Immunol 1981; 26: 226-231.
21. Garg D, Ali R. Reactive oxygen speices modified polyguanylic acid: Immunogenicity and implication for systemic autoimmunity. J Autoimmun 1998; 11: 371-378.
22. Tasneem S, Ali R. Antigenicity of poly(I) and ROS-poly (I) and their recognition of human anti-DNA autoantibodies. Immunol Invest 2001; 30: 335-345.
23. Maniatis T, Fritsch EF, Sambrook J eds. Extraction and purification of plasmid DNA. In Molecular Cloning: A Laboratory Manual, 1st edn. New York: Cold Spring Laboratory Press, 1982, 1.38-1.41.
24. Sugiuira Y, Matsumoto T Nucleotide selective cleavage of duplex DNA by nitric oxide. Biochem Biophys Res Commun 1994; 211: 748-753.
25. Ali R, Alam K. Evaluation of antibodies against oxygen free radical modified DNA by ELISA. In Armstrong ED ed. Oxidative Stress Biomarkers and Antioxidant Protocols. USA: Humana Press, 2002, 171-181.
26. Ali A, Hasan R, Ali R. Antigen binding diversity of affinity purified autoanitbodies against DNA. Biochem Int 1991; 23: 111-118.
27. Alam K, Ali R. Human autoantibody binding to multiple conformation of DNA. Biochem Int 1992; 26: 597-605.
28. Goding JW. Use of staphylococcal protein-A as immunological reagent. J Immunol Methods 1978; 20: 241-254.
29. Burton K. A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1956; 62: 315-323.
30. Bradford MM. A rapid and sensitive method for the quantitation of micrograms quantity of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-254.
31. Langmuir I. The adsorption of gases on plane surface of glass, mica and platinum. J Am Chem Soc 1918; 40: 1361-1403.
32. Zack DK, Yamamoto K, Wong AL, Stempnaik M, French C, Weisart RH. DNA mimics a self protein that may be target for some anti-DNA antibodies in systemic lupus erythematosus. J Immunol 1995; 154: 1987-1994.
33. Holan V, Krulova M, Zajicova A, Pindjakova J. Nitric oxide as a regulatory and effector molecule in the immune system. Mol Immunol 2002; 38: 989-995.
34. van der Veen RC. Nitric oxide and T helper cell immunity. Immunopharmacol 2001; 8: 1491-1500.
35. Gilkeson GS, Mudgett JS, Seldin MF et al. Clinical and serological manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med 1997; 186: 365-373.
36. Ho CY, Wong CK, Li EK, Tam LS, Lam CW. Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus. Rheumatology 2003; 42: 117-122.
37. Pisetsky DS. Anti-DNA antibodies in systemic lupus erythematosus. Rheum Dis Clin North Am 1992; 18: 437-454.
38. Hermann M, Winkler TH, Fehr H, Kalden JR. Preferential recognition of specific DNA motifs by its double stranded DNA autoantibodies. Eur J Immunol 1995; 25: 1897-1904.
39. Halliwell B, Aruoma OI. DNA damage by oxygen derived species-its mechanism and measurement in mammalian systems. FEBS Lett 1991; 28: 9-19.
40. Lin JK, Wang JM, Lin-Shiau SY. Relaxation of rat thorasic aorta by N-nitroso compounds and nitroprusside and their modifications of nucleic acid bases through nitric oxide release. Biochem Pharmacol 1993; 45: 819-825.
41. Ahsan A, Ali A, Ali R. Review: Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol 2003; 131: 398-404.